Logo image of SPNS

SAPIENS INTERNATIONAL CORP (SPNS) Stock Fundamental Analysis

NASDAQ:SPNS - Nasdaq - KYG7T16G1039 - Common Stock - Currency: USD

28.51  +0.57 (+2.04%)

Premarket: 28.61 +0.1 (+0.35%)

Fundamental Rating

6

Overall SPNS gets a fundamental rating of 6 out of 10. We evaluated SPNS against 284 industry peers in the Software industry. SPNS has an excellent profitability rating, but there are some minor concerns on its financial health. SPNS is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year SPNS was profitable.
SPNS had a positive operating cash flow in the past year.
SPNS had positive earnings in each of the past 5 years.
Each year in the past 5 years SPNS had a positive operating cash flow.
SPNS Yearly Net Income VS EBIT VS OCF VS FCFSPNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

1.2 Ratios

The Return On Assets of SPNS (10.19%) is better than 87.32% of its industry peers.
With an excellent Return On Equity value of 15.80%, SPNS belongs to the best of the industry, outperforming 82.75% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 13.51%, SPNS belongs to the top of the industry, outperforming 91.20% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SPNS is in line with the industry average of 12.33%.
The last Return On Invested Capital (13.51%) for SPNS is above the 3 year average (11.66%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 10.19%
ROE 15.8%
ROIC 13.51%
ROA(3y)9.12%
ROA(5y)7.74%
ROE(3y)14.05%
ROE(5y)12.52%
ROIC(3y)11.66%
ROIC(5y)9.93%
SPNS Yearly ROA, ROE, ROICSPNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

SPNS has a Profit Margin of 13.37%. This is in the better half of the industry: SPNS outperforms 79.58% of its industry peers.
SPNS's Profit Margin has improved in the last couple of years.
The Operating Margin of SPNS (15.90%) is better than 83.80% of its industry peers.
SPNS's Operating Margin has improved in the last couple of years.
SPNS's Gross Margin of 44.32% is on the low side compared to the rest of the industry. SPNS is outperformed by 71.13% of its industry peers.
In the last couple of years the Gross Margin of SPNS has grown nicely.
Industry RankSector Rank
OM 15.9%
PM (TTM) 13.37%
GM 44.32%
OM growth 3Y8.27%
OM growth 5Y6.35%
PM growth 3Y9.13%
PM growth 5Y10.59%
GM growth 3Y2.52%
GM growth 5Y2%
SPNS Yearly Profit, Operating, Gross MarginsSPNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SPNS is creating some value.
SPNS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SPNS has more shares outstanding
The debt/assets ratio for SPNS has been reduced compared to a year ago.
SPNS Yearly Shares OutstandingSPNS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
SPNS Yearly Total Debt VS Total AssetsSPNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

There is no outstanding debt for SPNS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.25
Altman-Z N/A
ROIC/WACC1.44
WACC9.4%
SPNS Yearly LT Debt VS Equity VS FCFSPNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

SPNS has a Current Ratio of 1.68. This is a normal value and indicates that SPNS is financially healthy and should not expect problems in meeting its short term obligations.
SPNS's Current ratio of 1.68 is in line compared to the rest of the industry. SPNS outperforms 51.76% of its industry peers.
SPNS has a Quick Ratio of 1.68. This is a normal value and indicates that SPNS is financially healthy and should not expect problems in meeting its short term obligations.
SPNS has a Quick ratio (1.68) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 1.68
SPNS Yearly Current Assets VS Current LiabilitesSPNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.47% over the past year.
SPNS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.51% yearly.
SPNS shows a small growth in Revenue. In the last year, the Revenue has grown by 3.84%.
The Revenue has been growing by 10.74% on average over the past years. This is quite good.
EPS 1Y (TTM)6.47%
EPS 3Y7.3%
EPS 5Y13.51%
EPS Q2Q%2.78%
Revenue 1Y (TTM)3.84%
Revenue growth 3Y5.57%
Revenue growth 5Y10.74%
Sales Q2Q%1.38%

3.2 Future

The Earnings Per Share is expected to grow by 4.30% on average over the next years.
SPNS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.96% yearly.
EPS Next Y-1.19%
EPS Next 2Y3.57%
EPS Next 3Y4.3%
EPS Next 5YN/A
Revenue Next Year5.12%
Revenue Next 2Y6.01%
Revenue Next 3Y5.96%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SPNS Yearly Revenue VS EstimatesSPNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
SPNS Yearly EPS VS EstimatesSPNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

SPNS is valuated rather expensively with a Price/Earnings ratio of 19.26.
80.63% of the companies in the same industry are more expensive than SPNS, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.57. SPNS is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 18.08, which indicates a rather expensive current valuation of SPNS.
Based on the Price/Forward Earnings ratio, SPNS is valued a bit cheaper than 77.11% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.41. SPNS is around the same levels.
Industry RankSector Rank
PE 19.26
Fwd PE 18.08
SPNS Price Earnings VS Forward Price EarningsSPNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

88.03% of the companies in the same industry are more expensive than SPNS, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, SPNS is valued cheaper than 82.04% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.18
EV/EBITDA 12.71
SPNS Per share dataSPNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The excellent profitability rating of SPNS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.43
EPS Next 2Y3.57%
EPS Next 3Y4.3%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.07%, SPNS has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 16.42, SPNS pays a better dividend. On top of this SPNS pays more dividend than 96.13% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, SPNS has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.07%

5.2 History

The dividend of SPNS is nicely growing with an annual growth rate of 21.00%!
SPNS has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of SPNS decreased in the last 3 years.
Dividend Growth(5Y)21%
Div Incr Years2
Div Non Decr Years2
SPNS Yearly Dividends per shareSPNS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

43.74% of the earnings are spent on dividend by SPNS. This is a bit on the high side, but may be sustainable.
SPNS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP43.74%
EPS Next 2Y3.57%
EPS Next 3Y4.3%
SPNS Yearly Income VS Free CF VS DividendSPNS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
SPNS Dividend Payout.SPNS Dividend Payout, showing the Payout Ratio.SPNS Dividend Payout.PayoutRetained Earnings

SAPIENS INTERNATIONAL CORP

NASDAQ:SPNS (6/16/2025, 8:09:29 PM)

Premarket: 28.61 +0.1 (+0.35%)

28.51

+0.57 (+2.04%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)08-04 2025-08-04/bmo
Inst Owners37.96%
Inst Owner Change1.94%
Ins Owners1.55%
Ins Owner ChangeN/A
Market Cap1.59B
Analysts48
Price Target31.96 (12.1%)
Short Float %2.73%
Short Ratio5.03
Dividend
Industry RankSector Rank
Dividend Yield 2.07%
Yearly Dividend0.57
Dividend Growth(5Y)21%
DP43.74%
Div Incr Years2
Div Non Decr Years2
Ex-Date04-07 2025-04-07 (0.36)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.36%
Min EPS beat(2)0.43%
Max EPS beat(2)2.3%
EPS beat(4)3
Avg EPS beat(4)-0.09%
Min EPS beat(4)-3.53%
Max EPS beat(4)2.3%
EPS beat(8)6
Avg EPS beat(8)0.76%
EPS beat(12)7
Avg EPS beat(12)-0.41%
EPS beat(16)11
Avg EPS beat(16)1.72%
Revenue beat(2)0
Avg Revenue beat(2)-2.56%
Min Revenue beat(2)-3.15%
Max Revenue beat(2)-1.97%
Revenue beat(4)0
Avg Revenue beat(4)-2.95%
Min Revenue beat(4)-4.1%
Max Revenue beat(4)-1.97%
Revenue beat(8)0
Avg Revenue beat(8)-2.14%
Revenue beat(12)1
Avg Revenue beat(12)-2.32%
Revenue beat(16)1
Avg Revenue beat(16)-2.18%
PT rev (1m)3.3%
PT rev (3m)3.3%
EPS NQ rev (1m)-1.84%
EPS NQ rev (3m)-12.59%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.61%
Revenue NQ rev (1m)0.4%
Revenue NQ rev (3m)1.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.92%
Valuation
Industry RankSector Rank
PE 19.26
Fwd PE 18.08
P/S 2.93
P/FCF 20.18
P/OCF 17.89
P/B 3.46
P/tB 12.18
EV/EBITDA 12.71
EPS(TTM)1.48
EY5.19%
EPS(NY)1.58
Fwd EY5.53%
FCF(TTM)1.41
FCFY4.96%
OCF(TTM)1.59
OCFY5.59%
SpS9.74
BVpS8.24
TBVpS2.34
PEG (NY)N/A
PEG (5Y)1.43
Profitability
Industry RankSector Rank
ROA 10.19%
ROE 15.8%
ROCE 16.67%
ROIC 13.51%
ROICexc 22.38%
ROICexgc N/A
OM 15.9%
PM (TTM) 13.37%
GM 44.32%
FCFM 14.51%
ROA(3y)9.12%
ROA(5y)7.74%
ROE(3y)14.05%
ROE(5y)12.52%
ROIC(3y)11.66%
ROIC(5y)9.93%
ROICexc(3y)18.66%
ROICexc(5y)15.72%
ROICexgc(3y)280.24%
ROICexgc(5y)293.68%
ROCE(3y)14.39%
ROCE(5y)12.25%
ROICexcg growth 3Y-14.28%
ROICexcg growth 5Y38.34%
ROICexc growth 3Y17.38%
ROICexc growth 5Y14.34%
OM growth 3Y8.27%
OM growth 5Y6.35%
PM growth 3Y9.13%
PM growth 5Y10.59%
GM growth 3Y2.52%
GM growth 5Y2%
F-Score6
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.25
Debt/EBITDA 0
Cap/Depr 52.55%
Cap/Sales 1.86%
Interest Coverage 250
Cash Conversion 84.2%
Profit Quality 108.52%
Current Ratio 1.68
Quick Ratio 1.68
Altman-Z N/A
F-Score6
WACC9.4%
ROIC/WACC1.44
Cap/Depr(3y)44.6%
Cap/Depr(5y)44.64%
Cap/Sales(3y)1.85%
Cap/Sales(5y)2.21%
Profit Quality(3y)92.81%
Profit Quality(5y)112.61%
High Growth Momentum
Growth
EPS 1Y (TTM)6.47%
EPS 3Y7.3%
EPS 5Y13.51%
EPS Q2Q%2.78%
EPS Next Y-1.19%
EPS Next 2Y3.57%
EPS Next 3Y4.3%
EPS Next 5YN/A
Revenue 1Y (TTM)3.84%
Revenue growth 3Y5.57%
Revenue growth 5Y10.74%
Sales Q2Q%1.38%
Revenue Next Year5.12%
Revenue Next 2Y6.01%
Revenue Next 3Y5.96%
Revenue Next 5YN/A
EBIT growth 1Y7.47%
EBIT growth 3Y14.29%
EBIT growth 5Y17.77%
EBIT Next Year2.39%
EBIT Next 3Y6.67%
EBIT Next 5YN/A
FCF growth 1Y106.15%
FCF growth 3Y1.68%
FCF growth 5Y8.06%
OCF growth 1Y87.01%
OCF growth 3Y0.69%
OCF growth 5Y4.44%